HER2 Positive Cancer Treatment
Appleglc.com is your HER2 oncology hub — trastuzumab, pertuzumab, trastuzumab deruxtecan, and tucatinib guidance for HER2-positive breast, gastric, and lung cancer patients.
Herceptin
Trastuzumab
Perjeta
Pertuzumab
Kadcyla
Ado-trastuzumab Emtansine
Enhertu
Fam-Trastuzumab Deruxtecan-nxki
Phesgo
Pertuzumab/Trastuzumab/Hyaluronidase-zzxf
Kanjinti
Trastuzumab-anns
Herzuma
Trastuzumab-pkrb
Ogivri
Trastuzumab-dkst
Trazimera
Trastuzumab-qyyp
Ontruzant
Trastuzumab-dttb
Tykerb
Lapatinib
Tukysa
Tucatinib
Nerlynx
Neratinib
Margenza
Margetuximab-cmkb
Cyramza
Ramucirumab
Keytruda
Pembrolizumab
Opdivo
Nivolumab
Avastin
Bevacizumab
Mvasi
Bevacizumab-awwb
Zirabev
Bevacizumab-bvzr
Taxol
Paclitaxel
Taxotere
Docetaxel
Abraxane
Paclitaxel Protein-Bound Particles
Xeloda
Capecitabine
Platinol
Cisplatin
Paraplatin
Carboplatin
Eloxatin
Oxaliplatin
Gemzar
Gemcitabine Hydrochloride
Navelbine
Vinorelbine
Adriamycin
Doxorubicin Hydrochloride
Tecentriq
Atezolizumab
Imfinzi
Durvalumab
Bavencio
Avelumab
Libtayo
Cemiplimab-rwlc
Opdualag
Nivolumab and Relatlimab-rmbw
Nivolumab SC
Nivolumab and Hyaluronidase-nvhy
Pembrolizumab IV
Pembrolizumab
Herceptin Hylecta
Trastuzumab and Hyaluronidase-oysk
Phesgo SC
Pertuzumab/Trastuzumab/Hyaluronidase-zzxf
Lonsurf
Trifluridine and Tipiracil Hydrochloride